Kristie Lauterbach Email

Director Quality Assurance . lungtx.com

Austin, TX

Location

LinkedIn

Current Roles

Employees:
22
Revenue:
$3.4M
About
Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. The company is developing a proprietary pipeline of therapeutics with the potential to greatly improve outcomes over currently available treatments. The company's lead drug candidate, LTI-01, is in clinical development for Loculated Pleural Effusion (LPE) and has successfully completed a clinical trial in LPE patients. The company's second drug candidate, LTI-03, is in clinical development for Idiopathic Pulmonary Fibrosis (IPF).
lungtx.com Address
2600 Via Fortuna
Austin, TX
United States
lungtx.com Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.